Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
Clinical trial NCT00708162 · COMPLETED
Trial details
- NCT number
- NCT00708162
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 724
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.